Freeline Therapeutics Holdings plc

FRLN Stock Healthcare Biotechnology
$6.48
+0.00 (+0.00%)
Price as of Oct 14, 2026 market close

Performance

1 Month
+0.0%
3 Months
+0.0%
YTD
+0.0%
1 Year
+27.3%
3 Year annualized
+21.3%
5 Year annualized
-33.4%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
46.1%
Largest decline max drawdown, last 5 years
-95.7%
Risk-adjusted return Sharpe ratio, 1-year
0.74

Own FRLN?

See how FRLN contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.